Score Overview
Explore the 2021 public Archive ranking →
Where USANA Health Sciences Inc has ranked, year by year
Not enough ranking history to display a chart
This chart needs at least two years of available HDB Score rankings on 30 years of fundamentals. USNA does not have enough ranked years in the public Archive through 2021.
More recent Archive years are available with Membership. Coverage varies by company and measure.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-29 | $ 14.70 | — |
1 Year2025-09-29 | $ 27.66 | -46.85% |
5 Years2021-09-29 | $ 91.72 | -83.97% |
10 Years2016-09-29 | $ 68.11 | -78.42% |
20 Years2006-09-29 | $ 22.30 | -34.07% |
30 Years1996-09-27 | $ 3.09 | 375.14% |
All Time1996-07-25 | $ 2.63 | 460.00% |
| Period | Last Price2026-09-29 | 1 Year2025-09-29 | 5 Years2021-09-29 | 10 Years2016-09-29 | 20 Years2006-09-29 | 30 Years1996-09-27 | All Time1996-07-25 |
|---|---|---|---|---|---|---|---|
| Price | $ 14.70 | $ 27.66 | $ 91.72 | $ 68.11 | $ 22.30 | $ 3.09 | $ 2.63 |
| Return | — | -46.85% | -83.97% | -78.42% | -34.07% | 375.14% | 460.00% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 913M | -$ 22M | |
| 2025 | $ 925M | $ 10M | $ 158M |
| 2024 | $ 854M | $ 42M | $ 181M |
| 2023 | $ 921M | $ 63M | $ 330M |
| 2022 | $ 998M | $ 69M | $ 288M |
| 2021 | $ 1.18B | $ 116M | $ 239M |
| 2020 | $ 1.13B | $ 124M | $ 312M |
| 2019 | $ 1.06B | $ 100M | $ 234M |
| 2018 | $ 1.18B | $ 126M | $ 277M |
| 2017 | $ 1.04B | $ 62M | $ 247M |
| 2016 | $ 1.00B | $ 100M | $ 175M |
| 2015 | $ 918M | $ 94M | $ 143M |
| 2014 | $ 790M | $ 76M | $ 111M |
| 2013 | $ 718M | $ 79M | $ 145M |
| 2012 | $ 648M | $ 66M | $ 70M |
| 2011 | $ 581M | $ 50M | $ 50M |
| 2010 | $ 517M | $ 45M | $ 24M |
| 2009 | $ 436M | $ 33M | $ 13M |
| 2008 | $ 429M | $ 29M | $ 13M |
| 2007 | $ 423M | $ 45M | $ 12M |
| 2006 | $ 374M | $ 41M | $ 27M |
| 2005 | $ 327M | $ 38M | $ 10M |
| 2004 | $ 272M | $ 30M | $ 15M |
| 2003 | $ 200M | $ 20M | $ 18M |
| 2002 | $ 133M | $ 8M | $ 6M |
| 2001 | $ 114M | $ 2M | $ 2M |
| 2000 | $ 123M | $ 2M | $ 2M |
| 1999 | $ 129M | $ 5M | $ 1M |
| 1998 | $ 121M | $ 9M | $ 2M |
| 1997 | $ 85M | $ 6M | $ 2M |
| IPO1996 | $ 56M | $ 5M | $ 1M |
USANA Health Sciences Inc fundamental performance
Between 2005 and 2025, revenue grew from $ 327M to $ 925M and net income declined from $ 38M to $ 10M. Revenue increased in 15 of those 20 years; net income in 10.
Across USANA Health Sciences Inc's full reported history, from 1996 to 2025, revenue grew from $ 56M to $ 925M and net income grew from $ 5M to $ 10M. Revenue increased in 77% of the years measured; net income in 57%.
USANA Health Sciences Inc currently holds a 20-year HDB Score of 3.7 out of 10. How the HDB Score is calculated.
Membership
Explore USNA with current data
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,814 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
